These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 2692636

  • 21. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].
    Etain B, Bonnet-Perrin E.
    Encephale; 2001; 27(3):280-9. PubMed ID: 11488259
    [Abstract] [Full Text] [Related]

  • 22. The psychopharmacology of obsessive compulsive disorder. Implications for treatment and pathogenesis.
    McDougle CJ, Goodman WK, Leckman JF, Price LH.
    Psychiatr Clin North Am; 1993 Dec; 16(4):749-66. PubMed ID: 8309811
    [Abstract] [Full Text] [Related]

  • 23. Treating the anxiety: therapeutic options in obsessive compulsive disorder.
    Greist JH.
    J Clin Psychiatry; 1990 Nov; 51 Suppl():29-34. PubMed ID: 2146255
    [Abstract] [Full Text] [Related]

  • 24. New pharmacologic approaches to obsessive compulsive disorder.
    Insel TR.
    J Clin Psychiatry; 1990 Oct; 51 Suppl():47-51; discussion 56-8. PubMed ID: 2120204
    [Abstract] [Full Text] [Related]

  • 25. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients.
    Zohar J, Kaplan Z, Benjamin J.
    J Clin Psychiatry; 1993 Oct; 54(10):385-8. PubMed ID: 7903293
    [Abstract] [Full Text] [Related]

  • 26. The potential role of serotonin reuptake inhibitors in the treatment of obsessive compulsive disorder.
    Zak JP, Miller JA, Sheehan DV, Fanous BS.
    J Clin Psychiatry; 1988 Aug; 49 Suppl():23-9. PubMed ID: 3045108
    [Abstract] [Full Text] [Related]

  • 27. Serotonin and treatment in obsessive-compulsive disorder.
    March JS, Gutzman LD, Jefferson JW, Greist JH.
    Psychiatr Dev; 1989 Aug; 7(1):1-18. PubMed ID: 2508084
    [Abstract] [Full Text] [Related]

  • 28. Clomipramine in obsessive-compulsive disorder: clinical response and plasma levels.
    Mavissakalian MR, Jones B, Olson S, Perel JM.
    J Clin Psychopharmacol; 1990 Aug; 10(4):261-8. PubMed ID: 2286699
    [Abstract] [Full Text] [Related]

  • 29. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH.
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [Abstract] [Full Text] [Related]

  • 30. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
    Korff S, Harvey BH.
    Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
    [Abstract] [Full Text] [Related]

  • 31. The antidepressant effects of 5-HT uptake inhibitors.
    Aberg-Wistedt A.
    Br J Psychiatry Suppl; 1989 Dec; (8):32-40. PubMed ID: 2692638
    [Abstract] [Full Text] [Related]

  • 32. Hallucinogens, serotonin and obsessive-compulsive disorder.
    Delgado PL, Moreno FA.
    J Psychoactive Drugs; 1998 Dec; 30(4):359-66. PubMed ID: 9924841
    [Abstract] [Full Text] [Related]

  • 33. Clomipramine: an antiobsessional tricyclic antidepressant.
    Peters MD, Davis SK, Austin LS.
    Clin Pharm; 1990 Mar; 9(3):165-78. PubMed ID: 2180623
    [Abstract] [Full Text] [Related]

  • 34. Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder.
    Pigott TA, Zohar J, Hill JL, Bernstein SE, Grover GN, Zohar-Kadouch RC, Murphy DL.
    Biol Psychiatry; 1991 Mar 01; 29(5):418-26. PubMed ID: 2018816
    [Abstract] [Full Text] [Related]

  • 35. OCD: where the serotonin selectivity story begins.
    Pigott TA.
    J Clin Psychiatry; 1996 Mar 01; 57 Suppl 6():11-20. PubMed ID: 8647793
    [Abstract] [Full Text] [Related]

  • 36. Pharmacologic therapy of obsessive compulsive disorder.
    DeVeaugh-Geiss J.
    Adv Pharmacol; 1994 Mar 01; 30():35-52. PubMed ID: 7833296
    [Abstract] [Full Text] [Related]

  • 37. Clomipramine use in obsessive-compulsive disorder.
    Ivey JL, Rosenberg DR.
    Expert Rev Neurother; 2002 Nov 01; 2(6):783-90. PubMed ID: 19810911
    [Abstract] [Full Text] [Related]

  • 38. The serotonin hypothesis of obsessive compulsive disorder.
    Barr LC, Goodman WK, Price LH.
    Int Clin Psychopharmacol; 1993 Nov 01; 8 Suppl 2():79-82. PubMed ID: 8201248
    [Abstract] [Full Text] [Related]

  • 39. Obsessive-compulsive disorder and serotonin: is there a connection?
    Insel TR, Mueller EA, Alterman I, Linnoila M, Murphy DL.
    Biol Psychiatry; 1985 Nov 01; 20(11):1174-88. PubMed ID: 2413912
    [Abstract] [Full Text] [Related]

  • 40. Role of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder.
    Koo MS, Kim EJ, Roh D, Kim CH.
    Expert Rev Neurother; 2010 Feb 01; 10(2):275-90. PubMed ID: 20136383
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.